In Conditions

Follow this topic

Record learning outcomes

Dermalex, the clinically proven skincare treatment for mild to moderate rosacea, psoriasis and eczema, is being launched into independent community pharmacies for the first time. Developed by dermatologists, the range delivers effective yet tolerable products that provide sufferers with an alternative choice to steroid and topical antibiotic treatments, says manufacturer Omega Pharma. The launch is supported by a £1.5 million investment €“ Omega Pharma's biggest spend with pharmacy to date.

The investment also supports category training through the company's seminars and improved resources, which offer information and advice on the products, as well as the physical and emotional impacts of skin conditions.